🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Lovely Flower and Talk at #LGN2024

We are hosting the South of England Genetic Epidemiology Group (SEGEG) meeting at the University of Exeter on July 1st! Registration is free and now open - forms.office.com/e/tengc4eKLk

✅ Registration is OPEN for the 2024 UK Biobank Scientific Conference in London! Join us on 10th December at the QEII Centre for ground-breaking research, innovative developments, and networking opportunities. Learn more and register here: ow.ly/EtJc50SrAzF

So excited to share my research with my colleagues at the #ExeterCancerNetwork ☺️ Anyone interested in cancer research, PPI at University of Exeter is welcome to join us！！ Also thanks my PhD supervisor Harry for the gift to celebrate my upgrade ✅ #phdjourney

Abstract submissions are now open for the Ca-PRI conference! 👩‍🔬🌎 Present your groundbreaking primary care cancer research to an international audience of clinicians, researchers, policy leaders, and more. ✨ 📅 Deadline: Friday 1st November 🔗 ow.ly/kNh350TLQ7P

The AllofUsResearch whole genome sequence dataset includes variation at >1 billion locations. Researchers can use this unprecedented resource to identify novel pharmacogenetic variants & variants predictive of disease! Learn more at allof-us.org/43u3m2K #ASHG24

Large biobank resources are transforming epidemiological research🧑‍🤝‍🧑🧬🧪 Key elements: 👉large sample sizes 👉genetics 👉deep phenotyping with omics/imaging 👉longitudinal follow-up with access to EHR 👉global data access to researchers Great review📖: nature.com/articles/s4157…

UK Biobank to be further enriched with epigenetic data for 50,000 participants❗️ #deepest #phenotyped #cohort #in #history🧬 🔗nanoporetech.com/news/oxford-na…

Next up on the stage of #DUKPC: Professor Ines Barroso Inês Barroso shares insights from her #research journey, showing how her expertise in genetics is helping to answer key questions for people living with #diabetes— all in her inspiring Dorothy Hodgkin Lecture. 🧬

📢 We’re hiring! Exciting opportunities for three Postdoctoral Researchers in Human Genetics and Health Data Science to join our team. ✉️ Get in touch at [email protected] or apply here: lnkd.in/ehbFPu5u (applications close on 26th March 2025)

Registration is open for the Genomics England Research Summit! Held on 17 June in London, this year’s agenda will explore groundbreaking research, technologies, and collaborations driving advances in genomics. Spaces are limited, register here: ow.ly/ha8450Vlg6b #GERS2025

SPCR leveraged Study Reveals Wide Variation in Prostate Cancer Testing tinyurl.com/3xh674ps

Learn about the past, present, and future of AI in clinical genetics. Benjamin Solomon nature.com/articles/s4143…

14% of 55-69 men with polygenic risk scores (PRS) in the top 10% had prostate cancer classified as intermediate or higher risk, a higher percentage than would have been identified using PSA or MRI screening. This seems like a strong argument for integrating polygenic risk scores

A simple at-home spit test may be more accurate at detecting prostate cancer than the current prostate-specific antigen (PSA) blood test, new NIHR-funded research suggests. NIHR Royal Marsden BRC with @ICRLondon and CRF 🔗 nihr.ac.uk/news/home-spit…

Done my first oral presentation #CaPRI2025 🧬Combining the PSA and Genetic Risk Scores (GRS) model to predict PCa is better than PSA or GRS alone! APEx (also on Blue Sky)

11:30 Tuesday @ Space1+2, come and join my talk with C34.03-Combining the GRS/PRS🧬and PSA🩸test results together to predict the prostate cancer #ESHG2025

#ESHG2025 Mia Neri Award for best presentation in cancer research. Jingzhan Lu,Exeter, United Kingdom "Predicting prostate cancer by combining Prostate Specific Antigen (PSA) test results with Genetic Risk Scores (GRS)"